Computational study on the mechanism of small molecules inhibiting NLRP3 with ensemble docking and molecular dynamic simulations
Open Access
- 3 March 2025
- journal article
- research article
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 26 (1) , 1-12
Abstract
NLRP3 (Nucleotide-binding oligomerization domain, LRR and pyrin domain-containing protein 3) is a pivotal regulator of inflammation, with strong implications in gout, neurodegenerative diseases, and various inflammatory conditions. Consequently, the exploration of NLRP3 inhibitors is of great significance for the treatment of diseases. MCC950, NP3-146, compound (3), and YQ128 are four highly bioactive NLRP3 inhibitors that show great potential; however, their mechanism of action is currently limited to targeting the ATP binding region (NACHT site) of the NLRP3 protein. To gain deeper insights into the defining features of NLRP3 inhibitors and to develop more potent inhibitors, it is imperative to elucidate the interaction mechanism between NLRP3 and these inhibitors. In this study, we employ a comprehensive computational approach to investigate the binding mechanism between NLRP3 and representative inhibitors. Utilizing the molecular mechanics/generalized Born surface area (MM/GBSA) method, we calculate the binding free energy and pinpoint the key residues involved in the binding of the four inhibitors to NLRP3. The decomposition of binding free energy by the MM/GBSA method reveals that the residues Val71, Arg195, Ile255, Phe419, Arg422, and Met505, situated around the binding pocket, play a crucial role in conferring the high bioactivity of NLRP3 inhibitors. Furthermore, pharmacophore analysis of the four NLRP3 complexes indicates that the primary interaction between the inhibitors and NLRP3 was mainly hydrophobic interaction. Our study provides a profound understanding of the interaction mechanism between NLRP3 and its inhibitors, identifies the key residues involved, and provides theoretical guidance for the design of more efficient NLRP3 inhibitors.Keywords
Funding Information
- the Natural Foundation of Shandong Province (ZR2022MB134)
- the project of Weifang University of Science and Technology (2024XJKJ06)
This publication has 51 references indexed in Scilit:
- Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K)Journal of Biomolecular Structure and Dynamics, 2016
- Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation studyPhysical Chemistry Chemical Physics, 2015
- Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 ProteaseJournal of Chemical Information and Modeling, 2015
- The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinitiesExpert Opinion on Drug Discovery, 2015
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesNature Medicine, 2015
- Prediction of Small Molecule Hydration Thermodynamics with Grid Cell TheoryJournal of Chemical Theory and Computation, 2013
- Thermodynamic Analysis of mRNA Cap Binding by the Human Initiation Factor eIF4E via Free Energy PerturbationsJournal of the American Chemical Society, 2009
- Accurate Prediction of the Relative Potencies of Members of a Series of Kinase Inhibitors Using Molecular Docking and MM-GBSA ScoringJournal of Medicinal Chemistry, 2006
- Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum ModelsAccounts of Chemical Research, 2000
- Protein normal-mode dynamics: Trypsin inhibitor, crambin, ribonuclease and lysozymeJournal of Molecular Biology, 1985